Signet Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.09M | Sell |
3,983
-20
| -0.5% | -$10.5K | 0.26% | 120 |
|
2025
Q1 | $2.54M | Buy |
4,003
+83
| +2% | +$52.6K | 0.34% | 97 |
|
2024
Q4 | $2.79M | Sell |
3,920
-110
| -3% | -$78.4K | 0.36% | 88 |
|
2024
Q3 | $4.24M | Buy |
4,030
+5
| +0.1% | +$5.26K | 0.54% | 56 |
|
2024
Q2 | $4.23M | Buy |
4,025
+5
| +0.1% | +$5.26K | 0.57% | 50 |
|
2024
Q1 | $3.87M | Buy |
4,020
+78
| +2% | +$75.1K | 0.53% | 60 |
|
2023
Q4 | $3.46M | Sell |
3,942
-1
| -0% | -$878 | 0.52% | 61 |
|
2023
Q3 | $3.25M | Sell |
3,943
-46
| -1% | -$37.9K | 0.54% | 60 |
|
2023
Q2 | $2.87M | Buy |
3,989
+24
| +0.6% | +$17.2K | 0.45% | 71 |
|
2023
Q1 | $3.26M | Buy |
3,965
+11
| +0.3% | +$9.04K | 0.55% | 58 |
|
2022
Q4 | $2.85M | Sell |
3,954
-33
| -0.8% | -$23.8K | 0.51% | 64 |
|
2022
Q3 | $2.75M | Buy |
3,987
+20
| +0.5% | +$13.8K | 0.54% | 53 |
|
2022
Q2 | $2.35M | Hold |
3,967
| – | – | 0.45% | 65 |
|
2022
Q1 | $2.77M | Buy |
3,967
+51
| +1% | +$35.6K | 0.46% | 62 |
|
2021
Q4 | $2.47M | Buy |
3,916
+42
| +1% | +$26.5K | 0.37% | 70 |
|
2021
Q3 | $2.35M | Buy |
3,874
+11
| +0.3% | +$6.66K | 0.4% | 71 |
|
2021
Q2 | $2.16M | Sell |
3,863
-4
| -0.1% | -$2.24K | 0.74% | 33 |
|
2021
Q1 | $1.83M | Sell |
3,867
-129
| -3% | -$61K | 0.34% | 86 |
|
2020
Q4 | $1.93M | Sell |
3,996
-107
| -3% | -$51.7K | 0.39% | 78 |
|
2020
Q3 | $2.41M | Sell |
4,103
-200
| -5% | -$117K | 0.53% | 55 |
|
2020
Q2 | $2.62M | Sell |
4,303
-495
| -10% | -$301K | 0.58% | 54 |
|
2020
Q1 | $2.68M | Sell |
4,798
-605
| -11% | -$337K | 0.63% | 52 |
|
2019
Q4 | $2.03M | Sell |
5,403
-113
| -2% | -$42.4K | 0.38% | 84 |
|
2019
Q3 | $1.9M | Sell |
5,516
-355
| -6% | -$122K | 0.37% | 86 |
|
2019
Q2 | $1.82M | Sell |
5,871
-785
| -12% | -$243K | 0.36% | 88 |
|
2019
Q1 | $2.23M | Sell |
6,656
-248
| -4% | -$83.2K | 0.44% | 80 |
|
2018
Q4 | $2.58M | Buy |
6,904
+6,475
| +1,509% | +$2.42M | 0.56% | 69 |
|
2018
Q3 | $173K | Buy |
429
+28
| +7% | +$11.3K | 0.03% | 239 |
|
2018
Q2 | $138K | Buy |
+401
| New | +$138K | 0.02% | 270 |
|